Unspecified condition associated with female genital organs and menstrual cycle 2016 2017 2018 2019 2020 2021 Billable/Specific Code N94.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Unsp cond assoc w female genital organs and menstrual cycle
Unspecified sexually transmitted disease 2016 2017 2018 2019 2020 2021 Billable/Specific Code A64 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM A64 became effective on October 1, 2020.
Indeterminate sex, unspecified. Q56.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM Q56.4 became effective on October 1, 2018. This is the American ICD-10-CM version of Q56.4 - other international versions of ICD-10 Q56.4 may differ.
N94.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM N94.9 became effective on October 1, 2019. This is the American ICD-10-CM version of N94.9 - other international versions...
ICD-10 code: Z20. 2 Contact with and exposure to infections with a predominantly sexual mode of transmission.
ICD-10 code Z11. 3 for Encounter for screening for infections with a predominantly sexual mode of transmission is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
For claims for screening for syphilis in pregnant women at increased risk for STIs use the following ICD-10-CM diagnosis codes: • Z11. 3 - Encounter for screening for infections with a predominantly sexual mode of transmission; • and any of: Z72. 89 - Other problems related to lifestyle, or Z72.
Z64.0ICD-10 code: Z64. 0 Problems related to unwanted pregnancy.
This policy describes reimbursement for Infectious agent detection by nucleic acid (DNA or RNA) assays for the detection of Sexually Transmitted Infections (STI), represented by CPT codes 87491, 87591, 87661, or 87801, and submitted for reimbursement on professional and facility claim forms.
2 - Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission.
411, Encounter for gynecological examination (general) (routine) with abnormal findings, or Z01. 419, Encounter for gynecological examination (general) (routine) without abnormal findings, may be used as the ICD-10-CM diagnosis code for the annual exam performed by an obstetrician–gynecologist.
Z00.00ICD-10 Code for Encounter for general adult medical examination without abnormal findings- Z00. 00- Codify by AAPC.
Other specified abnormal immunological findings in serum The 2022 edition of ICD-10-CM R76. 8 became effective on October 1, 2021.
O03.9ICD-10 Code for Complete or unspecified spontaneous abortion without complication- O03. 9- Codify by AAPC.
A missed abortion is a nonviable intrauterine pregnancy that has been retained within the uterus without spontaneous abortion. Typically, no symptoms exist besides amenorrhea, and the patient finds out that the pregnancy stopped developing earlier when a fetal heartbeat is not observed or heard at the appropriate time.
This legal definition may determine which CPT codes are selected: abortion (59812-59857) or delivery (59400-59515)....Medical Abortion.Possible CodeDescription59855-59857By suppositories before 20 weeksE/M CodeSpontaneous/Other Medical Abortion before 20 weeks3 more rows
During pregnancy, childbirth or the puerperium, a patient admitted (or presenting for a health care encounter) because of COVID-19 should receive a principal diagnosis code of O98.5- , Other viral diseases complicating pregnancy, childbirth and the puerperium, followed by code U07.1, COVID-19, and the appropriate codes for associated manifestation (s). Codes from Chapter 15 always take sequencing priority
Chapter 1: Certain Infectious and Parasitic Diseases (A00-B99) g. Coronavirus Infections. Code only a confirmed diagnosis of the 2019 novel coronavirus disease (COVID-19) as documented by the provider, documentation of a positive COVID-19 test result, or a presumptive positive COVID-19 test result.